Co-founder and CEO at Clerkenwell Health, a company dedicated to accelerating innovative mental health and CNS treatments through clinical trials to commercialisation. Clerkenwell has a specialism in the design and delivery of trials in psychedelics and the complexities that come with these treatments. Tom has a background in pharmaceutical consulting and digital health and is passionate about creating ways to enhance the patient experience.